Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock*

Authors

Ángel López

Published

January 1, 2004

Add a comment...

Supporters

Support the authors with ResearchCoin

Journal

Critical Care Medicine

Topics

DOI

10.1097/01.ccm.0000105581.01815.c6

Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock*

Authors

Ángel López

Published

January 1, 2004

Add a comment...

Supporters

Support the authors with ResearchCoin

Journal

Critical Care Medicine

Topics

DOI

10.1097/01.ccm.0000105581.01815.c6

Paper

Paper

Paper

Paper

Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock*

Supporters

Journal

Topics

DOI

Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock*

Supporters

Journal

Topics

DOI